查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1988291

微创手术市场：按设备类型、技术、应用和最终用户划分－2026-2032年全球市场预测

Minimally Invasive Surgery Market by Device Type, Technology, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，微创手术市场价值将达到 918.6 亿美元，到 2026 年将成长至 1,037.2 亿美元，到 2032 年将达到 2,220 亿美元，年复合成长率为 13.43%。

主要市场统计数据
基准年 2025 918.6亿美元
预计年份：2026年 1037.2亿美元
预测年份 2032 2220亿美元
复合年增长率 (%) 13.43%

微创手术模式转移中不断发展的临床实践和技术突破的舞台。

在技​​术突破和临床通讯协定不断改进的推动下，微创外科领域经历了快速变革。外科医师、医疗机构和医疗设备製造商通用携手合作，致力于提高手术精准度，同时减轻病患负担。随着临床医生从传统开放性手术转向内视镜手术，他们开始采用内视镜、先进的能量传输系统和高清视讯平台，以优化视野和操控。在此背景下，患者对更快康復的需求日益增长、医疗预算紧张以及医院患者容量压力不断增加等因素，正加速微创手术在全球范围内的普及。

揭示将重塑微创手术临床结果、医疗服务模式和医疗设备创新的变革性变化。

影像技术、仪器设计和手术流程的创新开启了微创调查方法的新时代，有望带来更高的精准度和更佳的患者预后。多光谱内频谱和先进能量仪器的普及突破了传统手术的限制，使医生能够进入解剖结构复杂且以往难以触及的区域。同时，即时数据迭加和扩增实境（AR）平台的整合增强了外科医生的术中情境察觉，提高了手术安全性，并减少了对试验试验的依赖。

评估美国将于 2025 年前实施的贸易关税政策对微创外科手术解决方案累积影响。

到了2025年，美国贸易关税的累积影响为微创手术器械的供应链带来新的复杂性。先进内视镜、能量产生器和机器人模组等零件的进口关税推高了依赖全球采购网路的製造商的成本。虽然一些公司已自行承担了部分额外成本以维持价格竞争力，但整个生态系统都面临着采购週期延长和供应商协议重新谈判的压力。

从设备类型、技术、应用和最终用户细分中获得关键见解，以推动 MIS 中的策略决策。

市场区隔分析显示，以内视镜、能量器材、腹腔镜器材和视讯平台为核心的设备组合，各自展现出独特的成长要素。在腹腔镜器械领域，材料科学和人体工学的稳定发展体现在分离器、格拉帕钳、牵开器、剪刀和套管针等器械中，从而提升了外科医生的舒适度和手术效率。随着这些器械不断适应日益复杂的手术情况，它们与先进成像和能量供应系统的集成，进一步凸显了硬体设计与临床工作流程之间至关重要的相互关係。

分析美洲、欧洲、中东和非洲以及亚太地区微创手术普及程度的区域差异和成长要素。

微创手术的区域趋势反映了不同地区在采用率上的差异，而这种差异受到医疗基础设施、报销模式和人口趋势的影响。在美洲，对医院维修和门诊设施扩建的大力投资正在推动先进平台的快速普及。此外，向价值医疗模式的转变鼓励采用能够缩短住院时间和最大限度减少术后併发症的治疗方法，从而进一步提升了对微创手术的需求。

分析微创手术领域主要企业的策略性倡议、技术合作和竞争地位。

微创手术领域的主要企业采取多元化策略，以巩固市场地位并加速创新。全球医疗设备製造商正在部署跨平台整合解决方案，将影像、能量照射和导航功能结合，旨在提供能够改善外科医生工作流程的综合手术室。透过策略收购机器人专家和能量设备创新者，这些企业正在强化其产品蓝图；同时，与学术机构的合作正在加速早期疗效检验和外科医生培训计画的发展。

为行业领导者提供切实可行的建议，以克服监管挑战、加速创新并优化进入 MIS 市场。

为了应对瞬息万变的环境，产业领导者应优先与监管机构合作，加速新医疗设备的核准流程，同时确保严格的安全标准。建立专门团队与监管机构合作，可简化临床试验设计，加速产品上市。同时，与支付方合作建构基于价值的报销机制，将增强微创手术的经济奖励，并促进医疗服务提供者更广泛地接受微创手术。

对 MIS 报告中为确保全面分析和可靠见解而采用的严谨、多方面的调查方法说明。

本报告整合了严谨的多层次调查方法所得出的洞见，旨在捕捉宏观趋势和特定产业的细微差别。主要研究包括对关键决策者（KOL）的深度访谈，其中包括门诊手术中心和医院的终端使用者、采购负责人以及临床KOL。这些一线观点为新兴医疗设备偏好和手术流程提供了至关重要的检验。

对微创手术实践中的关键趋势、策略挑战和未来前景进行综合分析，得出全面的结论。

总之，微创手术领域正处于技术创新与不断变化的医疗需求的交会点。从内视镜和能量传输系统到腹腔镜器械和影像设备，医疗设备的创新不断突破手术的可能性，而机器人辅助手术则不断拓展人体工学和精准度的边界。同时，价格压力和区域差异凸显了製定前瞻性供应链策略和立足本地市场的必要性。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 微创手术市场：依器械类型划分

  • 内视镜
  • 能源设备
  • 腹腔镜器械
    • 分离器
    • 夹爪
    • 牵开器
    • 剪刀
    • 套管针
  • 影像设备

第九章 微创手术市场：依技术划分

  • 手动的
  • 机器人辅助
    • 多臂机器人
    • 单臂机器人

第十章 微创手术市场：依应用领域划分

  • 循环系统
  • 一般外科
  • 妇科
  • 泌尿系统

第十一章 微创手术市场：依最终用户划分

  • 门诊手术中心
  • 医院
    • 初级保健
    • 二级医疗保健
    • 三级医疗保健

第十二章 微创手术市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章 微创手术市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 微创手术市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国微创手术市场

第十六章 中国微创手术市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • Arthrex, Inc.
  • B. Braun SE
  • Boston Scientific Corporation
  • Conmed Corporation
  • Cook Group Incorporated by The Cooper Companies, Inc.
  • Danaher Corporation
  • FUJIFILM Corporation
  • GE HealthCare Technologies Inc.
  • Getinge AB
  • Hoya Corporation
  • Intuitive Surgical, Inc.
  • Johnson & Johnson Services, Inc.
  • Karl Storz SE & Co. KG
  • Koninklijke Philips NV
  • Livanova PLC
  • Medtronic plc
  • Olympus Corporation
  • Richard Wolf GmbH
  • Siemens Healthineers AG
  • Smith & Nephew plc
  • Stryker Corporation
  • Synaptive Medical Inc.
  • Teleflex Incorporated
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-7A22CB0E591C

The Minimally Invasive Surgery Market was valued at USD 91.86 billion in 2025 and is projected to grow to USD 103.72 billion in 2026, with a CAGR of 13.43%, reaching USD 222.00 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 91.86 billion
Estimated Year [2026] USD 103.72 billion
Forecast Year [2032] USD 222.00 billion
CAGR (%) 13.43%

Setting the Stage for Evolving Clinical Practices and Technological Breakthroughs in the Changing Paradigm of Minimally Invasive Surgery

The landscape of minimally invasive surgery has undergone a rapid transformation driven by technological breakthroughs and evolving clinical protocols. Surgeons, healthcare institutions, and medical device manufacturers now converge around a shared goal of reducing patient trauma while enhancing procedural precision. As traditional open procedures give way to keyhole interventions, clinicians have embraced endoscopes, advanced energy delivery systems, and high-definition video platforms to optimize visualization and control. Against this backdrop, a confluence of factors-rising patient preference for faster recovery, tightening healthcare budgets, and mounting pressure on hospital throughput-has accelerated the adoption of minimally invasive approaches worldwide.

Moreover, the convergence of digital innovation and surgical technique has redefined the operating room. Cloud-based data analytics, AI-driven image guidance, and telecollaboration tools have enhanced preoperative planning and intraoperative decision making. Concurrently, educational institutions and professional societies have prioritized simulation-based training and credentialing programs to equip the next generation of surgeons with the skills required for complex minimally invasive procedures. Together, these dynamics have reshaped care pathways, elevating patient satisfaction, reducing length of stay, and creating a fertile ground for continued innovation across devices, robotics, and software ecosystems.

Unveiling the Transformative Shifts Reshaping Clinical Outcomes, Healthcare Delivery Models, and Device Innovation in Minimally Invasive Surgery

Innovations in imaging modalities, instrument design, and procedural workflows have ushered in a new era of minimally invasive methodologies that promise greater precision and improved patient outcomes. The proliferation of multi-spectrum endoscopes and advanced energy devices has transcended traditional barriers, enabling access to anatomically complex and previously unreachable regions. In parallel, the integration of real-time data overlays and augmented reality platforms has bolstered surgeons' situational awareness, fostering safer interventions and reducing reliance on trial-and-error techniques.

Furthermore, the rise of robotic-assisted platforms marks a transformative shift in how surgical teams collaborate and execute intricate procedures. Multiarm systems deliver enhanced dexterity and tremor filtration, allowing for micro-precision that surpasses human steadiness. At the same time, singlearm robotic modules are democratizing access by offering cost-efficient solutions for community hospitals and outpatient settings. This dual approach to automation underscores a broader trend toward modular, interoperable systems that can adapt to diverse case types across cardiovascular, gynecological, urological, and general surgical specialties.

Assessing the Cumulative Impact of U.S. Trade Tariff Policies Implemented by 2025 on the Adoption of Minimally Invasive Surgical Solutions

The cumulative effect of U.S. trade tariffs implemented by 2025 has introduced new complexities into the supply chain for minimally invasive surgical equipment. Import duties on components for advanced endoscopes, energy-based generators, and robotic modules have elevated costs for manufacturers relying on global sourcing networks. Although some companies have absorbed a portion of these additional expenses to maintain competitive pricing, the broader ecosystem has felt pressure through elongated procurement cycles and renegotiated vendor agreements.

Consequently, healthcare providers have recalibrated purchasing strategies to mitigate cost increases. Some institutions have prioritized domestically produced instruments, while others have sought long-term contracts to lock in pricing and guarantee supply continuity. Despite these headwinds, the drive toward procedural efficiency and clinical efficacy remains undiminished. As a result, manufacturers are exploring strategic partnerships and alternative component suppliers to navigate tariff-induced margins and preserve the trajectory of minimally invasive innovation.

Revealing Key Insights from Device Type, Technology, Application and End User Segmentation to Drive Strategic Decision-Making in MIS

Analysis of market segmentation reveals that device portfolios centered on endoscopes, energy devices, laparoscopic instruments, and video platforms each exhibit unique growth catalysts. Within the laparoscopic instruments category, instruments such as dissectors, graspers, retractors, scissors, and trocars demonstrate steady evolution in material science and ergonomics, enhancing both surgeon comfort and procedural efficiency. As these tools adapt to increasingly complex case mixes, their integration with advanced imaging and energy delivery systems further underscores the critical interplay between hardware design and clinical workflow.

Segmentation by technology highlights the contrast between manual approaches and robotic-assisted ecosystems. Manual instruments continue to benefit from incremental improvements in user interface and haptic feedback, supporting high-volume ambulatory surgery center procedures. Meanwhile, robotic-assisted solutions-spanning both multiarm and singlearm configurations-are enabling greater procedural versatility, particularly in intricate cardiovascular, gynecological, and urological interventions. Application-based insights underscore strong uptake in general surgery contexts, where standardization of protocols accelerates adoption, complemented by growing interest in niche procedures across oncology and endocrine specialties. Finally, understanding the end user landscape reveals that ambulatory surgery centers focus on high-throughput, cost-effective procedures, while hospitals across primary, secondary, and tertiary care tiers demand comprehensive systems capable of supporting complex case portfolios and integrated care pathways.

Highlighting Regional Variations and Growth Drivers Across the Americas, Europe Middle East Africa, and Asia Pacific in Minimally Invasive Surgery Adoption

Regional dynamics in minimally invasive surgery reflect disparate adoption rates influenced by healthcare infrastructure, reimbursement models, and demographic trends. In the Americas, robust capital investment in hospital renovation and outpatient facility expansion has underpinned strong uptake of advanced platforms. Additionally, policy shifts aimed at value-based care have incentivized interventions that reduce length of stay and minimize postoperative complications, further fueling demand for minimally invasive procedures.

Meanwhile, Europe, the Middle East and Africa exhibit heterogeneous growth pathways. Western Europe's mature healthcare systems continue to adopt incremental device innovations, whereas emerging markets in the Middle East are investing in center-of-excellence programs to establish surgical hubs of regional importance. Across Africa, capacity constraints and workforce training gaps present challenges, yet targeted public-private collaborations are beginning to introduce minimally invasive techniques in tertiary care facilities. In the Asia-Pacific region, expanding healthcare budgets, government initiatives to modernize public hospitals, and rising medical tourism converge to create a fertile environment for new equipment launches and localized manufacturing ventures.

Examining Leading Industry Players' Strategic Initiatives, Technological Collaborations, and Competitive Positioning in Minimally Invasive Surgery

Leading players in the minimally invasive surgery domain have pursued multifaceted strategies to reinforce their market positioning and accelerate innovation. Global device manufacturers have launched cross-platform integrations that combine imaging, energy delivery, and navigation capabilities, aiming to deliver comprehensive procedural suites that enhance surgeon workflow. Strategic acquisitions of robotics specialists and energy device innovators have bolstered their product roadmaps, while collaborative partnerships with academic centers facilitate early-stage validation and surgeon training programs.

At the same time, pure-play robotics developers continue to differentiate through next-generation platforms that prioritize modular design and artificial intelligence-driven assistance. By forging alliances with software firms and cloud-based analytics providers, these emerging entrants are redefining the standard for intraoperative decision support. Meanwhile, specialty companies focused on advanced optics and ergonomic instrument handles leverage niche expertise to influence broader system designs. Collectively, these competitive moves underscore a market characterized by both consolidation among incumbents and disruptive leaps from agile innovators.

Delivering Actionable Recommendations for Industry Leaders to Navigate Regulatory Challenges, Accelerate Innovation, and Optimize MIS Market Entry

To navigate the evolving landscape, industry leaders should prioritize regulatory engagement that expedites approval pathways for novel devices while ensuring rigorous safety standards. Establishing dedicated teams to collaborate with regulatory bodies can streamline clinical trial design and accelerate market entry. In parallel, forging partnerships with payer organizations to develop value-based reimbursement frameworks will solidify economic incentives for minimally invasive adoption and drive broader acceptance among healthcare providers.

Investment in modular robotic architectures that accommodate both multiarm and singlearm applications can unlock new revenue streams across diverse care settings. By offering scalable platforms, manufacturers can tailor solutions to the procedural requirements of ambulatory surgery centers, community hospitals, and tertiary care facilities. Moreover, integrating telecollaboration and remote monitoring functionalities will support surgeon training, postoperative follow-up, and cross-institutional best practice sharing.

Supply chain resilience must also be addressed through strategic sourcing and nearshoring initiatives that mitigate tariff-induced volatility. Building local manufacturing partnerships and diversifying component suppliers will enhance cost stability and ensure uninterrupted access to critical instrumentation. Finally, leveraging real-world evidence and data analytics to demonstrate clinical outcomes and cost savings will strengthen market positioning and facilitate payor negotiations, paving the way for sustained growth in the minimally invasive surgery arena.

Explaining the Rigorous Multi-Source Research Methodology Employed to Ensure Comprehensive Analysis and Credible Insights in MIS Reporting

This report synthesizes insights drawn from a rigorous multi-tiered research methodology designed to capture both macro-level trends and granular sector nuances. Primary research encompassed in-depth interviews with key opinion leaders, including end users in ambulatory surgery centers and hospitals, procurement specialists, and clinical thought leaders. These firsthand perspectives provided critical validation for emerging device preferences and procedural workflows.

Complementing this, secondary research involved systematic examination of published literature, regulatory filings, and white papers on surgical robotics, energy devices, and advanced imaging systems. Proprietary databases served to cross-reference OEM announcements, partnership disclosures, and clinical trial registries. The resulting analysis was then triangulated through expert workshops and peer reviews to ensure robustness and impartiality, yielding a comprehensive framework that supports strategic decision making.

Drawing Comprehensive Conclusions that Integrate Key Trends, Strategic Imperatives, and Future Outlooks for Minimally Invasive Surgical Practices

In conclusion, the minimally invasive surgery sector stands at the intersection of technological ingenuity and shifting healthcare imperatives. Device innovation across endoscopes, energy delivery systems, laparoscopic instruments, and video equipment continues to redefine procedural possibilities, while robotic assistance expands ergonomic and precision frontiers. Simultaneously, tariff pressures and regional disparities underscore the need for proactive supply chain strategies and localized market approaches.

Looking ahead, the successful deployment of minimally invasive solutions will hinge on cross-industry collaboration, regulatory foresight, and data-driven value demonstration. By aligning product development with clinician needs, forging payer partnerships, and embracing modular, interoperable platforms, stakeholders can navigate complexity and capture long-term growth opportunities. This executive summary provides a strategic blueprint for informed decision making in a rapidly evolving surgical environment.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Minimally Invasive Surgery Market, by Device Type

  • 8.1. Endoscopes
  • 8.2. Energy Devices
  • 8.3. Laparoscopic Instruments
    • 8.3.1. Dissectors
    • 8.3.2. Graspers
    • 8.3.3. Retractors
    • 8.3.4. Scissors
    • 8.3.5. Trocars
  • 8.4. Video Equipment

9. Minimally Invasive Surgery Market, by Technology

  • 9.1. Manual
  • 9.2. Robotic Assisted
    • 9.2.1. Multiarm Robots
    • 9.2.2. Singlearm Robots

10. Minimally Invasive Surgery Market, by Application

  • 10.1. Cardiovascular
  • 10.2. General Surgery
  • 10.3. Gynecology
  • 10.4. Urology

11. Minimally Invasive Surgery Market, by End User

  • 11.1. Ambulatory Surgery Centers
  • 11.2. Hospitals
    • 11.2.1. Primary Care
    • 11.2.2. Secondary Care
    • 11.2.3. Tertiary Care

12. Minimally Invasive Surgery Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Minimally Invasive Surgery Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Minimally Invasive Surgery Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Minimally Invasive Surgery Market

16. China Minimally Invasive Surgery Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Abbott Laboratories
  • 17.6. Arthrex, Inc.
  • 17.7. B. Braun SE
  • 17.8. Boston Scientific Corporation
  • 17.9. Conmed Corporation
  • 17.10. Cook Group Incorporated by The Cooper Companies, Inc.
  • 17.11. Danaher Corporation
  • 17.12. FUJIFILM Corporation
  • 17.13. GE HealthCare Technologies Inc.
  • 17.14. Getinge AB
  • 17.15. Hoya Corporation
  • 17.16. Intuitive Surgical, Inc.
  • 17.17. Johnson & Johnson Services, Inc.
  • 17.18. Karl Storz SE & Co. KG
  • 17.19. Koninklijke Philips N.V.
  • 17.20. Livanova PLC
  • 17.21. Medtronic plc
  • 17.22. Olympus Corporation
  • 17.23. Richard Wolf GmbH
  • 17.24. Siemens Healthineers AG
  • 17.25. Smith & Nephew plc
  • 17.26. Stryker Corporation
  • 17.27. Synaptive Medical Inc.
  • 17.28. Teleflex Incorporated
  • 17.29. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MINIMALLY INVASIVE SURGERY MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES MINIMALLY INVASIVE SURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA MINIMALLY INVASIVE SURGERY MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY ENERGY DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY ENERGY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY ENERGY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY LAPAROSCOPIC INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY LAPAROSCOPIC INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY LAPAROSCOPIC INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY LAPAROSCOPIC INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY DISSECTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY DISSECTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY DISSECTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY GRASPERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY GRASPERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY GRASPERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY RETRACTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY RETRACTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY RETRACTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY SCISSORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY SCISSORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY SCISSORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TROCARS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TROCARS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TROCARS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY VIDEO EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY VIDEO EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY VIDEO EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY MANUAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY MANUAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY MANUAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY ROBOTIC ASSISTED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY ROBOTIC ASSISTED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY ROBOTIC ASSISTED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY ROBOTIC ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY MULTIARM ROBOTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY MULTIARM ROBOTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY MULTIARM ROBOTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY SINGLEARM ROBOTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY SINGLEARM ROBOTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY SINGLEARM ROBOTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY GYNECOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY GYNECOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY GYNECOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY UROLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY UROLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY UROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY PRIMARY CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY PRIMARY CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY PRIMARY CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY SECONDARY CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY SECONDARY CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY SECONDARY CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TERTIARY CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TERTIARY CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TERTIARY CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS MINIMALLY INVASIVE SURGERY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS MINIMALLY INVASIVE SURGERY MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS MINIMALLY INVASIVE SURGERY MARKET SIZE, BY LAPAROSCOPIC INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS MINIMALLY INVASIVE SURGERY MARKET SIZE, BY ROBOTIC ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS MINIMALLY INVASIVE SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 82. AMERICAS MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS MINIMALLY INVASIVE SURGERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY LAPAROSCOPIC INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY ROBOTIC ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 89. NORTH AMERICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 90. NORTH AMERICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY LAPAROSCOPIC INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 96. LATIN AMERICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY ROBOTIC ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 97. LATIN AMERICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 98. LATIN AMERICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY LAPAROSCOPIC INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY ROBOTIC ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE MINIMALLY INVASIVE SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE MINIMALLY INVASIVE SURGERY MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE MINIMALLY INVASIVE SURGERY MARKET SIZE, BY LAPAROSCOPIC INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE MINIMALLY INVASIVE SURGERY MARKET SIZE, BY ROBOTIC ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE MINIMALLY INVASIVE SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE MINIMALLY INVASIVE SURGERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST MINIMALLY INVASIVE SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST MINIMALLY INVASIVE SURGERY MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST MINIMALLY INVASIVE SURGERY MARKET SIZE, BY LAPAROSCOPIC INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST MINIMALLY INVASIVE SURGERY MARKET SIZE, BY ROBOTIC ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 121. MIDDLE EAST MINIMALLY INVASIVE SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. MIDDLE EAST MINIMALLY INVASIVE SURGERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. AFRICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY LAPAROSCOPIC INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY ROBOTIC ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 129. AFRICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 131. AFRICA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC MINIMALLY INVASIVE SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC MINIMALLY INVASIVE SURGERY MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC MINIMALLY INVASIVE SURGERY MARKET SIZE, BY LAPAROSCOPIC INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC MINIMALLY INVASIVE SURGERY MARKET SIZE, BY ROBOTIC ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC MINIMALLY INVASIVE SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC MINIMALLY INVASIVE SURGERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 141. ASEAN MINIMALLY INVASIVE SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 142. ASEAN MINIMALLY INVASIVE SURGERY MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. ASEAN MINIMALLY INVASIVE SURGERY MARKET SIZE, BY LAPAROSCOPIC INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 144. ASEAN MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 145. ASEAN MINIMALLY INVASIVE SURGERY MARKET SIZE, BY ROBOTIC ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 146. ASEAN MINIMALLY INVASIVE SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 147. ASEAN MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 148. ASEAN MINIMALLY INVASIVE SURGERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 149. GCC MINIMALLY INVASIVE SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. GCC MINIMALLY INVASIVE SURGERY MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. GCC MINIMALLY INVASIVE SURGERY MARKET SIZE, BY LAPAROSCOPIC INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 152. GCC MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 153. GCC MINIMALLY INVASIVE SURGERY MARKET SIZE, BY ROBOTIC ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 154. GCC MINIMALLY INVASIVE SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 155. GCC MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 156. GCC MINIMALLY INVASIVE SURGERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPEAN UNION MINIMALLY INVASIVE SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPEAN UNION MINIMALLY INVASIVE SURGERY MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPEAN UNION MINIMALLY INVASIVE SURGERY MARKET SIZE, BY LAPAROSCOPIC INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPEAN UNION MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPEAN UNION MINIMALLY INVASIVE SURGERY MARKET SIZE, BY ROBOTIC ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPEAN UNION MINIMALLY INVASIVE SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPEAN UNION MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPEAN UNION MINIMALLY INVASIVE SURGERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 165. BRICS MINIMALLY INVASIVE SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. BRICS MINIMALLY INVASIVE SURGERY MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. BRICS MINIMALLY INVASIVE SURGERY MARKET SIZE, BY LAPAROSCOPIC INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 168. BRICS MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 169. BRICS MINIMALLY INVASIVE SURGERY MARKET SIZE, BY ROBOTIC ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 170. BRICS MINIMALLY INVASIVE SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 171. BRICS MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 172. BRICS MINIMALLY INVASIVE SURGERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 173. G7 MINIMALLY INVASIVE SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 174. G7 MINIMALLY INVASIVE SURGERY MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. G7 MINIMALLY INVASIVE SURGERY MARKET SIZE, BY LAPAROSCOPIC INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 176. G7 MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 177. G7 MINIMALLY INVASIVE SURGERY MARKET SIZE, BY ROBOTIC ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 178. G7 MINIMALLY INVASIVE SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 179. G7 MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. G7 MINIMALLY INVASIVE SURGERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 181. NATO MINIMALLY INVASIVE SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 182. NATO MINIMALLY INVASIVE SURGERY MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. NATO MINIMALLY INVASIVE SURGERY MARKET SIZE, BY LAPAROSCOPIC INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 184. NATO MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 185. NATO MINIMALLY INVASIVE SURGERY MARKET SIZE, BY ROBOTIC ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 186. NATO MINIMALLY INVASIVE SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 187. NATO MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. NATO MINIMALLY INVASIVE SURGERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 189. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. UNITED STATES MINIMALLY INVASIVE SURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 191. UNITED STATES MINIMALLY INVASIVE SURGERY MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. UNITED STATES MINIMALLY INVASIVE SURGERY MARKET SIZE, BY LAPAROSCOPIC INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 193. UNITED STATES MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 194. UNITED STATES MINIMALLY INVASIVE SURGERY MARKET SIZE, BY ROBOTIC ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 195. UNITED STATES MINIMALLY INVASIVE SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 196. UNITED STATES MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 197. UNITED STATES MINIMALLY INVASIVE SURGERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 198. CHINA MINIMALLY INVASIVE SURGERY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 199. CHINA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. CHINA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY LAPAROSCOPIC INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 201. CHINA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 202. CHINA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY ROBOTIC ASSISTED, 2018-2032 (USD MILLION)
  • TABLE 203. CHINA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 204. CHINA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 205. CHINA MINIMALLY INVASIVE SURGERY MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)